Advances in the Development of Pharmacological Chaperones for the Mucopolysaccharidoses.

Abstract excerpt

The mucopolysaccharidoses (MPS) are a group of 11 lysosomal storage diseases (LSDs) produced by mutations in the enzymes involved in the lysosomal catabolism of glycosaminoglycans. Most of the mutations affecting these enzymes may lead to changes in processing, folding, glycosylation, pH stability, protein aggregation, and defective transport to the lysosomes. It this sense, it has been proposed that the use of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Lysosomal Storage Diseases
• Share to Mucopolysaccharidosis II